1. Home
  2. DH vs TECX Comparison

DH vs TECX Comparison

Compare DH & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DH
  • TECX
  • Stock Information
  • Founded
  • DH 2011
  • TECX 2019
  • Country
  • DH United States
  • TECX United States
  • Employees
  • DH N/A
  • TECX N/A
  • Industry
  • DH Computer Software: Prepackaged Software
  • TECX
  • Sector
  • DH Technology
  • TECX
  • Exchange
  • DH Nasdaq
  • TECX Nasdaq
  • Market Cap
  • DH 280.0M
  • TECX 334.4M
  • IPO Year
  • DH 2021
  • TECX 2018
  • Fundamental
  • Price
  • DH $3.80
  • TECX $19.81
  • Analyst Decision
  • DH Hold
  • TECX Buy
  • Analyst Count
  • DH 10
  • TECX 7
  • Target Price
  • DH $5.10
  • TECX $78.67
  • AVG Volume (30 Days)
  • DH 713.0K
  • TECX 156.7K
  • Earning Date
  • DH 08-04-2025
  • TECX 08-13-2025
  • Dividend Yield
  • DH N/A
  • TECX N/A
  • EPS Growth
  • DH N/A
  • TECX N/A
  • EPS
  • DH N/A
  • TECX N/A
  • Revenue
  • DH $247,913,000.00
  • TECX N/A
  • Revenue This Year
  • DH N/A
  • TECX N/A
  • Revenue Next Year
  • DH $1.66
  • TECX N/A
  • P/E Ratio
  • DH N/A
  • TECX N/A
  • Revenue Growth
  • DH N/A
  • TECX N/A
  • 52 Week Low
  • DH $2.15
  • TECX $13.70
  • 52 Week High
  • DH $6.17
  • TECX $61.07
  • Technical
  • Relative Strength Index (RSI)
  • DH 66.68
  • TECX 40.56
  • Support Level
  • DH $3.55
  • TECX $22.13
  • Resistance Level
  • DH $3.95
  • TECX $25.75
  • Average True Range (ATR)
  • DH 0.19
  • TECX 1.44
  • MACD
  • DH 0.01
  • TECX -0.48
  • Stochastic Oscillator
  • DH 79.87
  • TECX 10.68

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: